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Abstract
The use of controlled mechanical ventilation (CMV) in patients who
experience weaning failure after a spontaneous breathing trial or
after extubation is a strategy based on the premise that respiratory
muscle fatigue (requiring rest to recover) is the cause of weaning
failure. Recent evidence, however, does not support the existence
of low frequency fatigue (the type of fatigue that is long-lasting) in
patients who fail to wean despite the excessive respiratory muscle
load. This is because physicians have adopted criteria for the
definition of spontaneous breathing trial failure and thus termination
of unassisted breathing, which lead them to put patients back on
the ventilator before the development of low frequency respiratory
muscle fatigue. Thus, no reason exists to completely unload the
respiratory muscles with CMV for low frequency fatigue reversal if
weaning is terminated based on widely accepted predefined
criteria. This is important, since experimental evidence suggests that
CMV can induce dysfunction of the diaphragm, resulting in
decreased diaphragmatic force generating capacity, which has
been called ventilator-induced diaphragmatic dysfunction (VIDD).
The mechanisms of VIDD are not fully elucidated, but include
muscle atrophy, oxidative stress and structural injury. Partial modes
of ventilatory support should be used whenever possible, since
these modes attenuate the deleterious effects of mechanical
ventilation on respiratory muscles. When CMV is used, concurrent
administration of antioxidants (which decrease oxidative stress and
thus attenuate VIDD) seems justified, since antioxidants may be
beneficial (and are certainly not harmful) in critical care patients.
Introduction
Controlled mechanical ventilation (CMV) is a mode of
ventilator support in which each breath is triggered by the
ventilator’s timer using a respiratory rate set by the clinician.
The characteristics of the breath are also set by the clinician,
i.e. pressure or flow controlled, volume, flow or time cycled.
Because the respiratory muscles are not contracting, the
minute ventilation is fully controlled by the ventilator, which
takes full responsibility for inflating the respiratory system.
CMV is traditionally used in severely ill patients who cannot
tolerate partial ventilatory support (e.g., acute respiratory
distress syndrome, septic shock, multiple organ failure), in
cases of overt patient-ventilator dysynchrony, and in the
immediate postoperative period. CMV is also used when
weaning fails (especially T-piece weaning) to rest the
respiratory muscle before the next weaning attempt. This
review will summarize recent evidence concerning the
deleterious effects of CMV on respiratory muscle function
and discuss the use of CMV during weaning failure.
Effects of CMV on the respiratory muscles:
evidence from animal models
Animal models have been used to unravel the effects of CMV
that are beneficial for the respiratory muscles: reversal of
respiratory muscle fatigue [1], prevention of muscle fiber
injury during a short-term (four hours) model of sepsis [2],
and restoration of perfusion to vital organs in shock states
when blood flow is ‘stolen’ by the intensely working
respiratory muscles [1,3].
Accumulating experimental evidence suggests, however, that
CMV can also induce dysfunction of the diaphragm, resulting
in decreased diaphragmatic force generating capacity,
diaphragmatic atrophy, and diaphragmatic injury, also called
ventilator-induced diaphragmatic dysfunction (VIDD) [4].
Ventilator-induced diaphragmatic dysfunction
In the intact diaphragm of various animal species (including
primates) studied in vivo after a period of CMV,
transdiaphragmatic pressure generation caused by phrenic
nerve stimulation declines at both submaximal and maximal
stimulation frequencies (20 to 100 Hz) in a time dependent
manner [5-7]. The decline is evident early and worsens as
mechanical ventilation is prolonged. Within a few days
(3 days in rabbits [7], 5 days in piglets [6], and 11 days in
baboons [5]) the pressure-generating capacity of the
diaphragm declines by 40% to 50%. The endurance of the
diaphragm is also significantly compromised, as suggested
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by the reduced ability of animals to sustain an inspiratory
resistive load [5].
The decreased force-generating capacity is not secondary to
changes in lung volume because transpulmonary pressure or
dynamic lung compliance do not change. Moreover, it is not
caused by changes in abdominal compliance, given the
nearly stable abdominal pressure over the observation period
and the similar results obtained with abdominal wrapping,
which prevents changes in abdominal compliance [5,6].
Neural or neuromuscular transmission remains intact as
reflected by the lack of changes in phrenic nerve conduction
(latency) and the stable response to repetitive stimulation of
the phrenic nerve [6]. In contrast, the decrease in the
compound muscle action potential suggests that excitation-
contraction coupling or membrane depolarization may be
involved in the dysfunction [6]. Thus, the mechanical
ventilation induced impairment of force generating capacity
appears to reside within the myofibers [4].
In vitro results of isometric (both twitch and tetanic) tension
development in isolated diaphragmatic strips confirm the in
vivo findings [8-13], and suggest that the decline in
contractility is an early (12 hours) [9] and progressive
phenomenon [9,14]. Isometric force development declines by
30% to 50% after 1 to 3 days of CMV in rats and rabbits,
though this time course might be prolonged in piglets [6],
which might suggest that the bigger the species, the longer it
takes for VIDD to develop.
The mechanisms of VIDD have not been fully elucidated.
Muscle atrophy, oxidative stress and structural injury have
been documented after CMV [4]. The precise contribution of
each to the development of VIDD has yet to be defined.
Muscle atrophy results from a combination of decreased
protein synthesis and increased proteolysis [15], and both
mechanisms have been documented in VIDD [16,17]. Of the
three intracellular proteolytic systems of mammalian cells
(lysosomal proteases, calpains and proteasomes), both
calpains and proteasomes are activated to induce atrophy
secondary to CMV [17]. The proteasome is a multisubunit
multicatalytic complex that exists in two major forms: the core
20S proteasome can be free or bound to a pair of 19S
regulators to form the 26S proteasome. Although the 26S
proteasome is activated with ventilator-induced cachexia
[14,18], Shanely et al. [17] showed that CMV resulted in a
five-fold increase in 20S proteasome activity, which is
specialized in degrading proteins oxidized by reactive oxygen
species [19]. Oxidative damage of a protein results in its
partial unfolding, exposing hidden hydrophobic residues;
therefore, an oxidized protein does not need to be further
modified by ubiquitin conjugation to confer a hydrophobic
patch, nor does it require energy from ATP hydrolysis to
unfold [20].
This result is in concert with the evidence for oxidative stress-
induced modification of proteins obtained from the
diaphragms of animals subjected to CMV [17,21]. Oxidative
stress is augmented in the diaphragm after CMV, as
indicated by the increased protein oxidation and lipid
peroxidation by-products [17,21]. The onset of oxidative
modifications is quite rapid, occurring within the first six hours
of the institution of CMV [21]. Oxidative stress can modify
many critical proteins involved in energetics, excitation-
contraction coupling, and force generation. Accordingly,
CMV-induced diaphragmatic protein oxidation was evident in
insoluble (but not soluble) proteins with molecular masses of
about 200, 128, 85, and 40 kDa [21]. These findings raise
the possibility that actin (40 kDa) and/or myosin (200 kDa)
undergo oxidative modification during CMV [21]. This
intriguing possibility awaits confirmation by more specific
identification of the modified proteins.
Structural abnormalities of different subcellular components
of diaphragmatic fibers have been found after CMV
[7,22,23]. The changes consist of disrupted myofibrils,
increased numbers of lipid vacuoles in the sarcoplasm, and
abnormally small mitochondria containing focal membrane
disruptions. Similar alterations were observed in the external
intercostal muscles of ventilated animals, but not in the hind
limb muscle [22]. The structural alterations in the myofibrils
have detrimental effects on diaphragmatic force-generating
capacity, the number of abnormal myofibrils being inversely
related to the force output of the diaphragm [7].
Clinical relevance of ventilator-induced diaphragmatic
dysfunction
Do we have evidence for VIDD in patients? Although
conclusive data do not exist, several intriguing observations
suggest VIDD may occur in patients. The twitch trans-
diaphragmatic pressure elicited by magnetic stimulation of the
phrenic nerves is reduced in ventilated patients compared with
normal subjects [24], and in patients ready to undergo weaning
trials [25]. Diaphragmatic atrophy was documented (by
ultrasound) in a tetraplegic patient after prolonged CMV [26].
The time course of atrophy, however, was not established.
Furthermore, denervation atrophy removes substances
originating from the nerve that are trophic for the muscle, which
is not the case in VIDD, as neural and neuromuscular functions
remain intact. The presence of confounding factors, such as
disease state (e.g., sepsis) and drug therapy (e.g., cortico-
steroids, neuromuscular blocking agents), makes documen-
tation of VIDD difficult in a clinical setting [4]. Nevertheless,
retrospective analysis of post-mortem data from neonates who
received ventilator assistance for 12 days or more before death
revealed diffuse diaphragmatic myofiber atrophy (small
myofibers with rounded outlines), which were not present in
extradiaphragmatic muscles [27].
The typical clinical scenario in which to suspect VIDD is a
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respiratory muscle dysfunction [4]. Other known causes of
respiratory muscle weakness such as shock, sepsis, major
malnutrition, electrolyte disturbances and neuromuscular
disorders, have been ruled out. For example, prolonged
neuromuscular blockade can be excluded by the lack of an
abnormal response to train-of-four stimulation; critical illness
polyneuropathy by the absence of neuropathic changes on
electrophysiologicaltesting; and acute quadriplegic myopathy
by the lack of corticosteroid exposure history (or by muscle
biopsy in indeterminate cases) [28].
At the present time, it seems prudent to suggest that the
period of time spent in CMV mode be curtailed as much as
possible, especially in older individuals. In fact, animal studies
suggest that the effects of aging and mechanical ventilation
are additive [29]. Although CMV induced similar losses
(24%) in diaphragmatic isometric tension in both young and
old animals, the combined effects of aging and CMV resulted
in 34% decrement in diaphragmatic isometric tension
compared to young control animals [29]. Furthermore, partial
modes of ventilatory support should be used whenever
possible, even in situations where CMV is classically used,
such as acute respiratory distress syndrome [30,31],
because assisted modes attenuate the deleterious effects of
mechanical ventilation on respiratory muscles [32]. Further
studies are needed to determine the amount of activity the
respiratory muscles should have to prevent VIDD. Preliminary
results (based on the force (Po) data of animals subjected to
three days of either assisted mechanical ventilation or CMV
and the electromyographic activity of the diaphragm) suggest
that partial diaphragm contractions at 25% or more of the
spontaneous breathing electromyographic activity can
significantly attenuate VIDD (C Sassoon, personal
communication). It is also not known whether periods of
intermittent activity (i.e., ‘exercise’ of the respiratory muscles)
can prevent or attenuate VIDD. Preliminary results in rats
suggest that allowing either 5 or 60 minutes of spontaneous
breathing every 6 hours of CMV to ‘exercise’ the respiratory
muscles could not significantly attenuate the decrease in
diaphragmatic force production induced by CMV despite
being adequate to prevent atrophy [33]. Whether more
frequent intervals of spontaneous breathing might be more
effective in this regard awaits experimental proof.
The use of CMV for respiratory muscle rest
during difficult weaning
The use of CMV in patients who experience weaning failure
after a spontaneous breathing trial or after extubation is a
strategy based on the premise that respiratory muscle fatigue
(requiring rest to recover) is the cause of weaning failure
[1,34]. This is because the load that the respiratory muscles of
patients who fail to wean are facing is increased to a range that
would predictably produce fatigue of the respiratory muscles
[35] if patients were allowed to continue spontaneous
breathing without ventilator assistance. Recent evidence,
however, does not support the existence of low frequency
fatigue (the type of fatigue that is long-lasting, taking more than
24 hours to recover) in patients who fail to wean despite the
excessive respiratory muscle load [25]. Twitch trans-
diaphragmatic pressure elicited by magnetic stimulation of the
phrenic nerve was not altered before and after the failing
weaning trials [25]. The tension-time index of the diaphragm
was 0.17 to 0.22 during failing weaning trials [25]. Bellemare
and Grassino [36] reported that the relationship between the
tension-time index of the diaphragm (TTdi) and time to task
failure in healthy subjects follows an inverse power function:
time to task failure = 0.1 (TTdi)–3.6. Based on this formula, the
expected times to task failure would be 59 to 28 minutes. The
average value of the TTdi during the last minute of the trial was
0.26, and patients undergoing weaning failure would be
predicted to sustain this effort for another 13 minutes before
development of diaphragmatic fatigue [25]. Thus, the lack of
low frequency respiratory muscle fatigue development despite
the excessive load is due to the fact that physicians have
adopted criteria for the definition of spontaneous breathing trial
failure, and thus termination of unassisted breathing, that lead
them to put patients back on the ventilator before the
development of low frequency respiratory muscle fatigue. Thus,
no reason exists to completely unload the respiratory muscles
with CMV for low frequency fatigue reversal if weaning is
terminated based on widely accepted predefined criteria.
Whether high frequency fatigue develops in patients who fail to
wean is not known. Even if this were the case, however, animal
studies suggest that complete unloading of the respiratory
muscles delays high frequency fatigue reversal, and thus CMV
should not be used [37,38].
The lack of fatigue, however, does not mean that the loaded
breathing associated with weaning failure is not injurious for
the respiratory muscles. Both animal models and human data
have shown that breathing against such loads (TTdi 0.17 to
0.22) can injure the respiratory muscles [39]. Nevertheless,
this injury peaks at about three days after the excessive
loading, which coincides with the documented decline in the
force-generating capacity of the diaphragm at this later time
point [39]. Thus, although weaning failure is not associated
with low frequency fatigue of the diaphragm at the time of
termination of spontaneous breathing trials, it may lead to the
onset of an injurious process in the respiratory muscles,
which is expected to peak later.
Whether CMV would be beneficial under these circum-
stances is not clear. All animal studies of VIDD to date have
been performed with previously normal diaphragm muscle.
We do not know, therefore, to what extent the response to
CMV might be modified by the baseline state of the
diaphragm. For instance, oxidative stress is implicated in the
loss of diaphragmatic force-generating capacity associated
with sepsis, as well as mechanical ventilation. Short-term
(four hours) CMV, however, actually improves force-
generating capacity of the diaphragm in sepsis and does not
appear to alter the level of oxidative stress under these
Available online http://ccforum.com/content/10/1/204conditions [2]. Along these same lines, the response to CMV
could conceivably be quite different in a diaphragm previously
loaded to the point of injury, which is also associated with
increased oxidative stress. Under these specific
circumstances, does CMV favour or prevent the development
of further oxidative stress, injury, and contractile dysfunction?
Moreover, once diaphragmatic injury has occurred, does
CMV facilitate or impair the subsequent muscle repair
process, particularly as evidence suggests that CMV alters
the expression of myogenic transcription factors involved in
muscle regeneration [40]? The answers to these important
questions await further study.
Antioxidants attenuate the detrimental effects of CMV
Given the central role of oxidative stress in the development
of VIDD, antioxidant supplementation could decrease the
oxidative stress and could thus attenuate VIDD. Accordingly,
when rats were administered the antioxidant Trolox (an
analogue of vitamin E) from the onset of CMV, its detrimental
effects on contractility and proteolysis were prevented [41].
Interestingly, a combination of vitamins E and C administered
to critically ill surgical (mostly trauma) patients was effective
in reducing the duration of mechanical ventilation compared
to non-supplemented patients [42]. It is tempting to
speculate that part of this beneficial effect was mediated by
preventing VIDD. Thus, when CMV is used, concurrent
administration of antioxidants seems justified, as a recent
metanalysis suggests that they are beneficial (and certainly
not harmful) in critical care patients [43].
Competing interests
The author(s) declare that they have no competing interests.
References
1. Vassilakopoulos T, Zakynthinos S, Roussos C: Respiratory
muscles and weaning failure. Eur Respir J 1996, 9:2383-2400.
2. Ebihara S, Hussain SN, Danialou G, Cho WK, Gottfried SB,
Petrof BJ: Mechanical ventilation protects against diaphragm
injury in sepsis: interaction of oxidative and mechanical
stresses. Am J Respir Crit Care Med 2002, 165:221-228.
3. Viires N, Sillye G, Aubier M, Rassidakis A, Roussos C: Regional
blood flow distribution in dog during induced hypotension
and low cardiac output. Spontaneous breathing versus artifi-
cial ventilation. J Clin Invest 1983, 72:935-947.
4. Vassilakopoulos T, Petrof BJ: Ventilator-induced diaphragmatic
dysfunction. Am J Respir Crit Care Med 2004, 169:336-341.
5. Anzueto A, Peters JI, Tobin MJ, de los SR, Seidenfeld JJ, Moore G,
Cox WJ, Coalson JJ: Effects of prolonged controlled mechani-
cal ventilation on diaphragmatic function in healthy adult
baboons. Crit Care Med 1997, 25:1187-1190.
6. Radell PJ, Remahl S, Nichols DG, Eriksson LI: Effects of pro-
longed mechanical ventilation and inactivity on piglet
diaphragm function. Intensive Care Med 2002, 28:358-364.
7. Sassoon CS, Caiozzo VJ, Manka A, Sieck GC: Altered
diaphragm contractile properties with controlled mechanical
ventilation. J Appl Physiol 2002, 92:2585-2595.
8. Le Bourdelles G, Viires N, Boczkowski J, Seta N, Pavlovic D,
Aubier M: Effects of mechanical ventilation on diaphragmatic
contractile properties in rats. Am J Respir Crit Care Med 1994,
149:1539-1544.
9. Powers SK, Shanely RA, Coombes JS, Koesterer TJ, McKenzie M,
Van Gammeren D, Cicale M, Dodd SL: Mechanical ventilation
results in progressive contractile dysfunction in the diaphragm.
J Appl Physiol 2002, 92:1851-1858.
10. Yang L, Luo J, Bourdon J, Lin MC, Gottfried SB, Petrof BJ: Con-
trolled mechanical ventilation leads to remodeling of the rat
diaphragm. Am J Respir Crit Care Med 2002, 166:1135-1140.
11. Gayan-Ramirez G, De Paepe K, Cadot P, Decramer M: Detrimen-
tal effects of short-term mechanical ventilation on diaphragm
function and IGF-I mRNA in rats. Intensive Care Med 2003, 29:
825-833.
12. Capdevila X, Lopez S, Bernard N, Rabischong E, Ramonatxo M,
Martinazzo G, Prefaut C: Effects of controlled mechanical venti-
lation on respiratory muscle contractile properties in rabbits.
Intensive Care Med 2003, 29:103-110.
13. Shanely RA, Coombes JS, Zergeroglu AM, Webb AI, Powers SK:
Short-duration mechanical ventilation enhances diaphrag-
matic fatigue resistance but impairs force production. Chest
2003, 123:195-201.
14. Zhu E, Sassoon CS, Nelson R, Pham HT, Zhu L, Baker MJ,
Caiozzo VJ: Early effects of mechanical ventilation on isotonic
contractile properties and MAF-box gene expression in the
diaphragm. J Appl Physiol 2005, 99:747-756.
15. Hussain SN, Vassilakopoulos T: Ventilator-induced cachexia.
Am J Respir Crit Care Med 2002, 166:1307-1308.
16. Shanely RA, Van Gammeren D, Deruisseau KC, Zergeroglu AM,
McKenzie MJ, Yarasheski KE, Powers SK: Mechanical ventilation
depresses protein synthesis in the rat diaphragm. Am J Respir
Crit Care Med 2004, 170:994-999.
17. Shanely RA, Zergeroglu MA, Lennon SL, Sugiura T, Yimlamai T,
Enns D, Belcastro A, Powers SK: Mechanical ventilation-
induced diaphragmatic atrophy is associated with oxidative
injury and increased proteolytic activity. Am J Respir Crit Care
Med 2002, 166:1369-1374.
18. Deruisseau KC, Kavazis AN, Deering MA, Falk DJ, Van Gammeren
D, Yimlamai T, Ordway GA, Powers SK: Mechanical ventilation
induces alterations of the ubiquitin-proteasome pathway in
the diaphragm. J Appl Physiol 2005, 98:1314-1321.
19. Davies KJ: Degradation of oxidized proteins by the 20S pro-
teasome. Biochimie 2001, 83:301-310.
20. Shringarpure R, Grune T, Mehlhase J, Davies KJ: Ubiquitin-con-
jugation is not required for the degradation of oxidized pro-
teins by the proteasome. J Biol Chem 2003, 278:311-318.
21. Zergeroglu MA, McKenzie MJ, Shanely RA, Van Gammeren D,
Deruisseau KC, Powers SK: Mechanical ventilation-induced
oxidative stress in the diaphragm. J Appl Physiol 2003, 95:
1116-1124.
22. Bernard N, Matecki S, Py G, Lopez S, Mercier J, Capdevila X:
Effects of prolonged mechanical ventilation on respiratory
muscle ultrastructure and mitochondrial respiration in rabbits.
Intensive Care Med 2003, 29:111-118.
23. Radell P, Edstrom L, Stibler H, Eriksson LI, Ansved T: Changes in
diaphragm structure following prolonged mechanical ventila-
tion in piglets. Acta Anaesthesiol Scand 2004, 48:430-437.
24. Watson AC, Hughes PD, Louise HM, Hart N, Ware RJ, Wendon J,
Green M, Moxham J: Measurement of twitch transdiaphragmatic,
esophageal, and endotracheal tube pressure with bilateral
anterolateral magnetic phrenic nerve stimulation in patients in
the intensive care unit. Crit Care Med 2001, 29:1325-1331.
25. Laghi F, Cattapan SE, Jubran A, Parthasarathy S, Warshawsky P,
Choi YS, Tobin MJ: Is weaning failure caused by low-frequency
fatigue of the diaphragm? Am J Respir Crit Care Med 2003,
167:120-127.
26. Ayas NT, McCool FD, Gore R, Lieberman SL, Brown R: Preven-
tion of human diaphragm atrophy with short periods of elec-
trical stimulation. Am J Respir Crit Care Med 1999,  159:
2018-2020.
27. Knisely AS, Leal SM, Singer DB: Abnormalities of diaphrag-
matic muscle in neonates with ventilated lungs. J Pediatr
1988, 113:1074-1077.
28. Deem S, Lee CM, Curtis JR: Acquired neuromuscular disorders
in the intensive care unit. Am J Respir Crit Care Med 2003,
168:735-739.
29. Criswell DS, Shanely RA, Betters JJ, McKenzie MJ, Sellman JE,
Van Gammeren DL, Powers SK: Cumulative effects of aging
and mechanical ventilation on in vitro diaphragm function.
Chest 2003, 124:2302-2308.
30. Zakynthinos SG, Vassilakopoulos T, Daniil Z, Zakynthinos E, Kout-
soukos E, Katsouyianni K, Roussos C: Pressure support ventila-
tion in adult respiratory distress syndrome: short-term effects
of a servocontrolled mode. J Crit Care 1997, 12:161-172.
Critical Care    Vol 10 No 1 Vassilakopoulos et al.
Page 4 of 5
(page number not for citation purposes)31. Putensen C, Zech S, Wrigge H, Zinserling J, Stuber F, Von
Spiegel T, Mutz N: Long-term effects of spontaneous breath-
ing during ventilatory support in patients with acute lung
injury. Am J Respir Crit Care Med 2001, 164:43-49.
32. Sassoon CS, Zhu E, Caiozzo VJ: Assist-control mechanical ven-
tilation attenuates ventilator-induced diaphragmatic dysfunc-
tion. Am J Respir Crit Care Med 2004, 170:626-632.
33. Gayan-Ramirez G, Testelmans D, Racz G, Maes K, Cadot P,
Zador E, Wuytack F, Decramer M: Intermittent spontaneous
breathing protects the rat diaphragm from the detrimental
effects of mechanical ventilation [abstract]. Am J Respir Crit
Care Med 2004, 169:A123.
34. Vassilakopoulos T, Roussos C, Zakynthinos S: Weaning from
mechanical ventilation. J Crit Care 1999, 14:39-62.
35. Vassilakopoulos T, Zakynthinos S, Roussos C: The tension-time
index and the frequency/tidal volume ratio are the major
pathophysiologic determinants of weaning failure and
success. Am J Respir Crit Care Med 1998, 158:378-385.
36. Bellemare F, Grassino A: Effect of pressure and timing of con-
traction on human diaphragm fatigue. J Appl Physiol 1982, 53:
1190-1195.
37. Uchiyama A, Imanaka H, Nishimura M, Taenaka N, Fujino Y,
Yoshiya I: Effects of pressure-support ventilation on recovery
from acute diaphragmatic fatigue in rabbits. Crit Care Med
1998, 26:1225-1230.
38. Uchiyama A, Imanaka H, Nishimura M, Taenaka N, Fujino Y,
Yoshiya I: Optimal level of pressure support ventilation for
recovery from diaphragmatic fatigue in rabbits. Crit Care Med
2000, 28:473-478.
39. Jiang TX, Reid WD, Road JD: Free radical scavengers and
diaphragm injury following inspiratory resistive loading. Am J
Respir Crit Care Med 2001, 164:1288-1294.
40. Racz G, Gayan-Ramirez G, De Paepe K, Zador E, Wuytack F,
Decramer M: Early changes in rat diaphragm biology with
mechanical ventilation. Am J Respir Crit Care Med 2003, 168:
297-304.
41. Betters JL, Criswell DS, Shanely RA, Van Gammeren D, Falk D,
Deruisseau KC, Deering M, Yimlamai T, Powers SK: Trolox atten-
uates mechanical ventilation-induced diaphragmatic dysfunc-
tion and proteolysis. Am J Respir Crit Care Med 2004, 170:
1179-1184.
42. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT,
Radella F, Garcia I, Maier RV: Randomized, prospective trial of
antioxidant supplementation in critically ill surgical patients.
Ann Surg 2002, 236:814-822.
43. Heyland D: Antioxidant nutrients:a systematic review of trace
elements and vitamins in the critically ill patient. Intensive
Care Med 2005, 31:327-337.
Available online http://ccforum.com/content/10/1/204
Page 5 of 5
(page number not for citation purposes)